STOCOSIL
Stocosil is a pharmaceutical company delivering next generation products that treat the double-threat of hypertension and high cholesterol. Stocosil strikes at the heart of cardiovascular disease with their lead drug product, Kubiqo —a dual-drug pill that simultaneously treats hypertension and high cholesterol, reducing risk by a dramatic 45%. Kubiqo is a fixed dose combination of olmesartan medoxomil and rosuvastatin calcium which currently does not exist in the United States. In addition to Kubiqo, Stocosil has a strong pipeline of products that will tap into a large global market and multi-billion dollar revenue potential. Stocosil boasts an impressive management team possessing significant experience in drug development.
STOCOSIL
Social Links:
Industry:
Health Care Pharmaceutical
Founded:
2014-12-01
Address:
City Of Industry, California, United States
Country:
United States
Website Url:
http://www.dev.stocosil.com
Total Employee:
1+
Status:
Active
Contact:
+1 (818) 852-5553
Email Addresses:
[email protected]
Total Funding:
750 K USD
Technology used in webpage:
DNS.COM
Similar Organizations
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Current Advisors List
Current Employees Featured
